HOXA-AS2 has been found to play a role in the development of gastric cancer, liver cancer, breast cancer, bladder cancer, intestinal cancer, and pancreatic cancer [9, 19–23] and has been reported to be related to tumor size and pathological stage and patient prognosis in gastric cancer. Here, HOXA-AS2 is linked to breast carcinoma.